Recent Trends In Pathology
Tuesday July 12, 1700-1800
 
Objectives:
At the end of this session, participants will be able to:

1. Summarize the basics of miRNA biogenesis and function.
2. Recognize the potential utility of miRNAs as disease biomarkers in body fluids and biopsies and how can this significantly improve patient management in the era of precision medicine.
3. Describe the challenges that face the use of miRNAs as clinical biomarkers and the transition from bench to bedside.
 
 
microRNAs: not very small after all
Vincent De Guire, Maisonneuve-Rosemont Hospital

MicroRNAs in Pathology: short RNAs go a long way
George M. Yousef, University of Toronto
 

Question Title

* 1. Please take a few minutes of your time to evaluate the scientific session.

  Yes No
Session objectives as stated above were adequately met.
The session met my expectations.
The session content was relevant and/or applicable to my work.
Adequate time was allocated for questions/discussion/interaction.
I would like to have had this session recorded for future viewing/listening.

Question Title

* 2. Outcomes: As a result of attending this session, I am planning to:

  Yes No
Discuss with Colleagues
Pursue additional learning activities
Complete a personal learning project
Change my practice

Question Title

* 3. If you answered yes, please indicate/describe what additional learning or knowledge you intend to pursue:

Question Title

* 4. If you answered yes, please indicate what changes you intend to integrate into practice:

T